Testing ways to predict stomach cancer risk
Part of Cancer, Digestive system clinical trials.
This trial looks at adults with stomach lining changes—either atrophic gastritis or intestinal metaplasia—and studies how to predict who may be at risk for stomach cancer. It may help earlier identification and closer monitoring for people with these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Have stomach biopsy results showing atrophic gastritis OR intestinal metaplasia
- The changes must be in the stomach area (antrum, body, and/or angular area)
- Have medical records that confirm the diagnosis was proven by tissue biopsy
- No specific extra medical conditions were listed as reasons to exclude you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with past or current H. pylori infection to better understand stomach lining changes such as atrophic gastritis and intestinal metaplasia, and to monitor for possible progression. It may help by improving how doctors track risk over time and use stored tissue samples to learn more.
This study collects health information from people at different stages of stomach cancer risk, including those with precancerous changes, healthy individuals, and those with early stomach cancer. The goal is to better understand and prevent stomach cancer.
This trial studies whether a condition called atrophic gastritis (thinning of the stomach lining) can help predict who is more likely to develop stomach cancer. It may help with early detection and prevention.
This study looks at people with certain stomach symptoms or precancer risk factors when they get a camera test of the upper digestive tract (endoscopy). The goal is to learn how to better detect and evaluate stomach precancer conditions early, which may help guide treatment or follow-up.
This study follows patients with pre-cancerous stomach conditions to learn more about how they progress. By collecting health information over time, researchers hope to improve early detection and treatment of stomach cancer.
This study looks for markers in the blood that could show if someone is at risk for stomach cancer or pre-cancerous changes. It aims to help catch problems earlier.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.